在非膜性心房动和临床结果中的甲状腺功能障碍
Zeni Chen1, Huaibin Wan2,3, Tingting Min3
1Department of Cardiology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
Endocrine
|April 22, 2024
概括
甲状腺功能障碍,特别是低三甲状腺素 (T3) 综合征,增加了患有非膜性心房动 (NVAF) 的患者的风险. 这种情况与心力衰竭,死亡和血栓栓塞的更高率有关.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 甲状腺功能障碍对心房动 (AF) 患者的影响仍未得到充分研究.
- 在非膜心肌动 (NVAF) 患者中调查甲状腺功能对于了解临床结果至关重要.
研究的目的:
- 检查甲状腺功能障碍与NVAF患者血栓栓塞风险之间的关系.
- 评估甲状腺功能与NVAF中的临床复合终点之间的关联.
主要方法:
- 在2016-2020年间诊断出1329名NVAF患者的回顾性分析.
- 评估甲状腺功能障碍,CHA2DS2-VASc分数和临床终点 (死亡,心力衰竭,栓塞,出血) 之间的相关性.
主要成果:
- 在6.7%的患者中观察到低三甲状腺素 (T3) 综合征.
- 较低的三甲氨酸 (TT3) 总水平与增加的血栓塞栓症风险相关 (P<0.005).
- 在调整的模型中,低T3综合征独立预测了临床复合终点 (HR1.68),心力衰竭 (HR1.52) 和全因死亡 (HR3.34) 的更高风险.
结论:
- 低T3综合征与NVAF患者心力衰竭和全因死亡风险增加有关.
- 低TT3水平的NVAF患者面临更高的血栓栓塞的风险.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
980
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
980
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
741
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
741
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K


